natgillin/translations-raw huggingface dataset:
A fall in blood pressure when standing (orthostatic hypotension) leading to dizziness when moving to a standing or sitting position.
padec krvnega tlaka v stoječem položaju (ortostatska hipotenzija), ki pri premiku v stoječi ali sedeči položaj povzroči omedlevico
A fall in serum ferritin values is very common (see section 4.4).
Padec feritina v serumu je zelo pogost (glejte poglavje 4.4).
A fall in the amount of haemoglobin in the blood (the substance in the red blood cells)
zmanjšanje količine hemoglobina v krvi (snovi v rdečih krvničkah),
A fall in the number of platelets in the blood
zmanjšanje števila krvnih ploščic v krvi,
A fall in the number of platelets in the blood
zmanjšanje števila trombocitov v krvi,
A fall in the number of red blood cells which may cause anaemia leading to tiredness and weakness
zmanjšanje števila eritrocitov, kar lahko povzroči anemijo, ki vodi v utrujenost in šibkost;
A fall in the number of red blood cells which may cause anaemia leading to tiredness and weakness.
zmanjšanje števila rdečih krvničk, ki lahko povzroči anemijo, ki privede do utrujenosti in šibkosti,
A fall in the number of red cells in the blood
zmanjšanje rdečih krvničk v krvi,
A fall in the number of red cells in the blood
zmanjšanje števila rdečih krvničk v krvi,
A fall in the number of red cells in the blood after an operation
zmanjšanje števila rdečih krvničk po operaciji,
A fall in the number of white blood cells (neutropenia) accompanied by fever and infection
padec števila belih krvničk (nevtropenija), ki ga spremljata povišana telesna temperatura in okužba,
a Faslodex is indicated in patients whose disease had recurred or progressed on an anti-estrogen therapy.
a Zdravilo Faslodex je indicirano pri bolnikih, katerih bolezen se je ponovila ali napredovala med zdravljenjem z antiestrogeni.
A fast and irregular heartbeat (atrial fibrillation).
hiter, nereden srčni utrip (atrijska fibrilacija),
A fast heart rate and abnormal heart sounds have been reported with INCRELEX treatment.
Pri zdravljenju z zdravilom INCRELEX so poročali o hitrem bitju srca in nepravilnih srčnih zvokih.
a fast or pounding heart beat
pospešen srčni utrip ali razbijanje srca
A fat-containing meal or snack should be consumed just before or after dosing.
Tik pred oziroma tik po odmerjanju zaužijte obrok ali prigrizek mastne hrane.
A fat-containing meal or snack should be given to your child just before or just after dosing (some examples are provided below).
Tik pred odmerjanjem ali tik po njem naj otrok dobi masten obrok ali prigrizek (nekaj primerov je navedenih spodaj).
A fatal acute myocardial infarction and cerebrovascular accident was reported in one patient each (0.3%).
O akutnem miokardnem infarktu ter cerebrovaskularnem insultu s smrtnim izidom so poročali pri po enem bolniku (0,3 %).
a Fatal cases have been reported in completed or ongoing clinical studies b Life-threatening cases have been reported in completed or ongoing clinical studies. c The frequency of adverse events in the cardiac disorders system organ class regardless of causality was higher in the nivolumab group than in the chemotherapy group in post-CTLA4/BRAF inhibitor metastatic melanoma population.
a V končanih študijah ali študijah, ki še potekajo, so poročali o smrtnih izidih. b V končanih študijah ali študijah, ki še potekajo, so poročali o smrtno nevarnih primerih. c V populaciji bolnikov z metastatskim melanomom, ki so se predhodno zdravili z zaviralcem CTLA4/BRAF, je bila pogostnost neželenih učinkov ne glede na vzrok v kategoriji bolezni srca po razvrstitvi glede na organske sisteme večja v skupini, ki se je zdravila z nivolumabom, kot v skupini, ki se je zdravila s kemoterapijo.
A fatal outcome was reported in an adolescent clinical trial patient with very low calcium levels in the blood (hypocalcaemia).
V kliničnem preskušanju pri mladostnikih so pri bolniku z zelo nizkimi vrdnostmi kalcija v krvi (hipokalciemijo) poročali o smrtnem izidu.
A fatal outcome was reported in an adolescent clinical trial patient with very low calcium levels in the blood (hypocalcaemia).
V kliničnem preskušanju pri mladostnikih so pri bolniku z zelo nizko koncentracijo kalcija v krvi (hipokalciemijo) poročali o smrtnem izidu.
A feeling of "spinning" (vertigo)
občutek "vrtenja" (vrtoglavica)
a feeling of confusion or disorientation, altered mood, restlessness
tanje zmedenosti ali dezorientacije, spremembe razpoloženja, nemir
a feeling of dizziness or spinning
občutek omotice ali vrtoglavice,
A feeling of fullness or a throbbing pain behind the nose, cheeks and eyes (sinusitis), pain in the abdomen, vomiting and diarrhoea, breathing problems
občutek zamašenosti ali utripajoča bolečina za nosom, lici in očmi (sinuzitis), bolečina v trebuhu, bruhanje in driska, težave z dihanjem,
a feeling of having something in the eye
občutek tujka v očesu
a feeling of having something in the eye
občutek, da imate nekaj v očesu
a feeling of not completely emptying the bladder, a more frequent need to pass water, even at night.
občutek, da mehur ni popolnoma izpraznjen pogostejša potreba po odvajanju vode, celo ponoči.
A feeling of spinning (vertigo)
občutek vrtenja (vrtoglavica)
a feeling of spinning or tilting (vertigo)
občutek vrtenja (vrtoglavica)
a feeling of spinning or tilting (vertigo), whistling, ringing or other persistent noise in the ears
občutek vrtenja ali nagibanja (vrtoglavica), žvižganje, piskanje ali drug vztrajen zvok v ušesu;
A feeling of tenderness and swelling in your stomach.
Občutljivost in napetost v trebuhu.
a feeling of tightness in the throat
občutek stiskanja v grlu
A feeling that something is in your eye
občutek tujka v očesu,
A fertility study of bupropion in rats at doses up to 300 mg/kg/day, or 8 times the bupropion dose provided by naltrexone / bupropion revealed no evidence of impaired fertility.
Študija plodnosti za bupropion pri podganah, ki so prejemale odmerke do 300 mg/kg/dan oziroma 8- kratnik odmerka bupropiona, ki ga vsebuje kombinacija naltrekson/bupropion, ni pokazala nobenih znakov zmanjšane plodnosti.
a fever due to an infection and low levels of white blood cells
zvišana telesna temperatura zaradi okužbe in majhnega števila belih krvnih celic,
a fever due to an infection and low levels of white blood cells, herpes zoster infection
povišana telesna temperatura zaradi okužbe ter nizko število belih krvnih celic, herpes zoster
A few cases have been reported during ulipristal acetate treatment or within 2-3 months after ulipristal acetate treatment was stopped.
O nekaj primerih so poročali med zdravljenjem z ulipristalacetatom ali 2–3 mesece po koncu zdravljenja z ulipristalacetatom.
A few cases of concurrent elevations in ALT greater than 3 x ULN and bilirubin greater than 2 x ULN have been observed with the subcutaneous formulation, however not in patients with acromegaly treated with pasireotide intramuscular use.
Pri zdravljenju s subkutano obliko zdravila so opažali nekaj primerov sočasno zvišanih vrednosti ALT nad 3-kratnik ZMN in vrednosti bilirubina nad 2-kratnik ZMN, česar pa niso opažali pri bolnikih z akromegalijo, ki so prejemali pasireotid za intramuskularno uporabo.
A few cases of skin lesions on elbows like little hard lumps have been reported in children treated with high doses of different cysteamine preparations.
Pri otrocih, zdravljenih z velikimi odmerki različnih pripravkov cisteamina, so poročali o nekaj primerih kožnih lezij na komolcih, ki so bili podobni trdim bulicam.
A few individuals have been reported, who carry PCSK9 loss-of-function mutations in two alleles and have profoundly low LDL-C levels, with HDL-C and TG levels in the normal range.
Opisanih je bilo nekaj nosilcev mutacije PCSK9 z izgubo funkcije na dveh alelih; te osebe imajo skrajno nizko koncentracijo LDL-H, koncentracijo HDL in TG pa v normalnem območju.
A few of the post-marketing reports of hepatic failure occurred in patients with no pre-existing hepatic disease or other identifiable risk factors (see section 4.8).
O odpovedi jeter so v obdobju trženja zdravila nekajkrat poročali tudi pri bolnikih brez predhodne bolezni jeter ali drugih odkritih dejavnikov tveganja (glejte poglavje 4.8).
A few of the post-marketing reports of hepatic failure, including cases in patients with no pre-existing hepatic disease or other identifiable risk factors, were characterized by a fulminant course, progressing in some cases to transplantation or death.
V nekaj postmarketinških poročilih o odpovedi jeter, vključno s primeri pri bolnikih brez predhodne bolezni jeter ali drugih odkritih dejavnikov tveganja, je bil opisan tudi fulminantni potek, ki je v nekaterih primerih napredoval do transplatacije ali smrti.
A few patients have experienced these serious side effects (may affect up to 1 in 1,000 people).
Te resne neželene učinke je imelo nekaj bolnikov (pojavijo se lahko pri do 1 od 1.000 ljudi).
A few patients have experienced these serious side effects (may affect up to 1 in 1,000 people).
Te resne neželene učinke je imelo nekaj bolnikov (pojavijo se lahko pri največ 1 od 1.000 bolnikov).
A few people who have had hypoglycaemia after switching from animal insulin to human insulin have reported that the early warning symptoms were less obvious or different.
Nekaj bolnikov, pri katerih se je po prehodu z živalskega insulina na humanega pojavila hipoglikemija, je poročalo, da so bili pri njih zgodnji opozorilni znaki manj opazni ali pa drugačni kot prej.
A few taps at the injection site will stimulate tiny nerve endings and help reduce discomfort when the needle goes in.
Z nekaj rahlimi udarci na mestu injiciranja boste vzburili živčne končiče, kar bo zmanjšalo neprijeten občutek ob vbodu igle.
A few tiny bubbles are not important and will not affect your dose in any way.
Prisotnost nekaj manjših mehurčkov ni pomembna in na noben način ne bo vplivala na odmerjanje.
a fibrate (e.g. fenofibrate, gemfibrozil) a statin (e.g. simvastatin, atorvastatin)
fibrat (npr. fenofibrat, gemfibrozil), statin (npr. simvastatin, atorvastatin),
A fibrin sealant is a type of glue that is made from human blood-clotting proteins.
Fibrinsko lepilo je vrsta lepila, izdelanega iz človeških beljakovin, ki povzročajo strjevanje krvi.
A field study has shown that in heartworm positive dogs with microfilaraemia there is a risk of severe respiratory signs (coughing, tachypnea and dyspnea) that may require prompt veterinary treatment.
Terenske raziskave so pokazale, da je pri psih, pozitivnih na srčno glisto, ki imajo mikrofilaremijo, velika možnost pojava resnih dihalnih znakov (kašelj, tahipneja, dispneja), ki zahtevajo takojšnje veterinarsko zdravljenje.
A field study in Japan involved cats with flea infestations which were either treated with Broadline or a spot-on medicine containing the active substance selamectin.
Terenska študija na Japonskem je zajela mačke z bolhami, ki so jih zdravili z zdravilom Broadline ali zdravilom za kožni nanos, ki je vsebovalo zdravilno učinkovino selamektin.
A field trial in chickens was performed to evaluate the effects of the vaccine against ILT and MD.
Izvedeno je bilo terensko preskušanje pri piščancih, v katerem so ocenjevali učinke cepiva proti infekcijskemu laringotraheitisu in Marekovi bolezni.
A field trial was also carried out.
Izvedena je bila tudi terenska študija.
A fifth study investigated the safety of Kalydeco granules in 34 patients aged between 2 and 5 years of age who had cystic fibrosis due to a G551D or S549N mutation.
V peti študiji so raziskovali varnost zrnc zdravila Kalydeco pri 34 bolnikih, starih od dve do pet let, ki so imeli cistično fibrozo zaradi oblik mutacij G551D ali S549N.
A final concentration of approximately 0.5 mg/ml busulfan should be achieved.
Končna koncentracija busulfana mora biti približno 0,5 mg/ml.
A final concentration of between 0.4 mg/ml to 1.2 mg/ml doxorubicin HCl, is required.
Končna koncentracija mora biti med 0,4 in 1,2 mg/ml doksorubicin klorid.
a fine-bore needle for subcutaneous injection, a sharps container for safe disposal of glass and needles.
fino iglo za podkožno injiciranje, zaščitno posodo za varno odstranjevanje stekla in igel.
A first episode of hospitalised, chest X-ray confirmed pneumonia was identified in about 2% of this population (n=1,814 subjects) of which 329 cases were confirmed pneumococcal CAP and 182 cases were VT pneumococcal CAP in the per protocol and modified intent to treat (mITT) populations.
Prvo epizodo pljučnice, ki je zahtevala hospitalizacijo in je bila potrjena z rentgenskim slikanjem prsnega koša, so odkrili pri približno 2 % te populacije (n = 1.814 preskušancev), od katerih je v populaciji po protokolu in v modificirani populaciji, ki jo nameravamo zdraviti (mITT – modified intent to treat), 329 preskušancev imelo potrjeno pnevmokokno CAP, 182 oseb pa potrjeno CAP zaradi VT-pnevmokoka.
A fixed-dose combination of budesonide and formoterol fumarate dihydrate should be administered with caution in patients with thyrotoxicosis, phaeochromocytoma, diabetes mellitus, untreated hypokalaemia, hypertrophic obstructive cardiomyopathy, idiopathic subvalvular aortic stenosis, severe hypertension, aneurysm or other severe cardiovascular disorders, such as ischaemic heart disease, tachyarrhythmias or severe heart failure.
Kombinacijo budezonida in formoterolijevega fumarat dihidrata v fiksnih odmerkih predpisujte previdno pri bolnikih s tirotoksikozo, feokromocitomom, sladkorno boleznijo, nezdravljeno hipokaliemijo, hipertrofično obstruktivno kardiomiopatijo, idiopatsko subvalvularno aortno stenozo, hudo hipertenzijo, anevrizmo ali drugimi hudimi kardiovaskularnimi boleznimi, kot so na primer ishemična srčna bolezen, tahiaritmije ali hudo srčno popuščanje.
a flare-up of symptoms related to an inactive infection in your body (immune reactivation);
izbruh simptomov, povezanih z neaktivno okužbo v vašem telesu (imunska reaktivacija);
a flare-up of symptoms related to an inactive infection in your body (immune reconstitution);
izbruh simptomov, povezanih z neaktivno okužbo v vašem telesu (imunska rekonstitucija);
A flow rate of greater than 60L/min is required for optimal delivery of drugs to the lungs through the multi- dose dry powder Spiromax inhaler.
Za optimalno dostavo zdravila v pljuča skozi večodmerni inhalator Spiromax, ki vsebuje suhi prašek, je potrebna hitrost pretoka nad 60 l/min.
A flu pandemic happens when a new strain of flu virus appears that can spread easily from person to person because
Pandemija gripe nastopi, ko se pojavi nov sev virusa gripe, ki se med ljudmi hitro širi, ker proti njemu niso imuni
A flu pandemic happens when a new strain of flu virus appears that can spread easily from person to person because people have no immunity (protection) against it.
Do pandemije gripe pride, ko se pojavi nov sev virusa gripe, ki se med ljudmi hitro širi, ker proti njemu niso imuni (oziroma pred njim niso zaščiteni).
A flu pandemic happens when a new strain of flu virus appears that can spread easily from person to person because people have no immunity (protection) against it.
Do pandemije pride, ko se pojavi nov sev virusa gripe, ki se med ljudmi hitro širi, ker proti njemu niso imuni (oziroma pred njim niso zaščiteni).
A flu pandemic happens when a new strain of flu virus appears that can spread easily from person to person because people have no immunity (protection) against it.
Pandemija gripe nastopi, ko se pojavi nov sev virusa gripe, ki se hitro širi med ljudmi, ker proti njemu ljudje nimajo imunosti (zaščite).
A flu pandemic happens when a new strain of flu virus appears that can spread easily from person to person because people have no immunity (protection) against it.
Pandemija gripe nastopi, ko se pojavi nov sev virusa gripe, ki se lahko brez težav širi s človeka na človeka, ker ljudje proti njemu niso imuni (zaščiteni).
A flu pandemic happens when a new strain of flu virus appears that can spread easily from person to person because people have no immunity (protection) against it.
Pandemija gripe nastopi, ko se pojavi nov sev virusa gripe, ki se med ljudmi hitro širi, ker proti njemu niso imuni (zaščiteni).
A flu pandemic happens when a new strain of flu virus appears that can spread easily from person to person because people have no immunity (protection) against it.
Pandemija gripe nastopi, ko se pojavi novi sev virusa gripe, ki se lahko brez težav širi s človeka na človeka, ker ljudje nanj niso imuni (zaščiteni proti njemu).
A flu pandemic happens when a new type (strain) of flu virus appears that can spread easily from person to person because people have no immunity (protection) against it.
Do pandemije gripe pride, ko se pojavi novi sev virusa gripe, ki se med ljudmi hitro širi, ker proti njemu niso imuni (zaščiteni).
A flu pandemic occurs when a new strain of flu virus appears that can spread easily because people have no immunity (protection) against it.
Pandemija nastopi, ko se pojavi nov sev virusa gripe, ki se lahko brez težav širi s človeka na človeka, ker ljudje nanj niso imuni (zaščiteni pred njim).
A flu pandemic occurs when a new type (strain) of flu virus emerges that can spread easily from person to person because people have no immunity (protection) against it.
Do pandemije gripe pride, ko se pojavi novi sev virusa gripe, ki se med ljudmi hitro širi, ker nanj niso imuni (zaščiteni).
A flu pandemic occurs when a new type (strain) of flu virus emerges that can spread easily from person to person because people have no immunity (protection) against it.
Pandemija gripe nastopi, ko se pojavi nova vrsta (sev) virusa gripe, ki se lahko enostavno širi od človeka do človeka, ker ljudje nanj niso imuni (zaščiteni proti njemu).
a flu-like feeling – chills and sweating
gripi podobno počutje – mrzlica in znojenje,
a flu-like feeling — chills and sweating
gripi podobno počutje – mrzlica in znojenje,
A follow-on (maintenance) pack containing 10 clear blisters of 14 x CHAMPIX 1 mg film-coated tablets in a carton.
Pakiranje za vzdrževalno zdravljenje, ki vsebuje 10 prozornih pretisnih omotov s po 14 filmsko obloženimi tabletami CHAMPIX 1 mg v škatli.
A follow-on (maintenance) pack containing 2 clear blisters of 14 x CHAMPIX 0.5 mg film-coated tablets in card packaging.
Pakiranje za vzdrževalno zdravljenje, ki vsebuje 2 prozorna pretisna omota s po 14 filmsko obloženimi tabletami CHAMPIX 0,5 mg, ki sta zavarjena v kartonskem pakiranju.
A follow-on (maintenance) pack containing 2 clear blisters of 14 x CHAMPIX 1 mg film-coated tablets in a carton.
Pakiranje za vzdrževalno zdravljenje, ki vsebuje 2 prozorna pretisna omota s po 14 filmsko obloženimi tabletami CHAMPIX 1 mg v škatli.
A follow-on (maintenance) pack containing 2 clear blisters of 14 x CHAMPIX 1 mg film-coated tablets in card packaging.
Pakiranje za vzdrževalno zdravljenje, ki vsebuje 2 prozorna pretisna omota s po 14 filmsko obloženimi tabletami CHAMPIX 1 mg, ki sta zavarjena v kartonskem pakiranju.
A follow-on (maintenance) pack containing 2 clear blisters of 28 x CHAMPIX 0.5 mg film-coated tablets in card packaging.
Pakiranje za vzdrževalno zdravljenje, ki vsebuje 2 prozorna pretisna omota s po 28 filmsko obloženimi tabletami CHAMPIX 0,5 mg, ki sta zavarjena v kartonskem pakiranju.
A follow-on (maintenance) pack containing 2 clear blisters of 28 x CHAMPIX 1 mg film-coated tablets in card packaging.
Pakiranje za vzdrževalno zdravljenje, ki vsebuje 2 prozorna pretisna omota s po 28 filmsko obloženimi tabletami CHAMPIX 1 mg, ki sta zavarjena v kartonskem pakiranju.
A follow-on (maintenance) pack containing 4 clear blisters of 14 x CHAMPIX 1 mg film-coated tablets in a carton.
Pakiranje za vzdrževalno zdravljenje, ki vsebuje 4 prozorne pretisne omote s po 14 filmsko obloženimi tabletami CHAMPIX 1 mg v škatli.
A follow-on (maintenance) pack containing 8 clear blisters of 14 x CHAMPIX 1 mg film-coated tablets in a carton.
Pakiranje za vzdrževalno zdravljenje, ki vsebuje 8 prozornih pretisnih omotov s po 14 filmsko obloženimi tabletami CHAMPIX 1 mg v škatli.
A forgotten dabigatran etexilate dose may still be taken up to 6 hours prior to the next scheduled dose.
Pozabljeni odmerek dabigatran eteksilata lahko bolnik vzame še do 6 ur pred naslednjim odmerkom.
A form to report medication errors.
obrazec za poročanje o napakah pri zdravljenju.
A fourth (booster) dose was given in six clinical studies to 1,976 subjects.
Četrti (obnovitveni) odmerek so v šestih kliničnih študijah dali 1.976 preiskovancem.
A fourth injection (booster) will be given between 11 and 15 months of age
Četrti (obnovitveni) odmerek bo prejel v starosti od 11 do 15 mesecev.
A fourth injection (booster) will be given between 11 and 15 months of age.
Četrti (obnovitveni) odmerek bo prejel v starosti od 11 do 15 mesecev.
A fourth injection (booster) will be given between 12 months and 15 months of age.
Četrta injekcija (poživitveni odmerek) se daje med 12. in 15. mesecem starosti.
A fourth main study involved 396 children aged between 1 and 17 years with complicated skin and soft tissue infections.
V četrto glavno študijo je bilo vključenih 396 otrok, starih od enega do 17 let, ki so imeli zapletene oblike okužbe kože in mehkih tkiv.
A fourth study investigated the effectiveness of Kalydeco in patients with cystic fibrosis who had the R117H mutation.
V četrti študiji so raziskovali učinkovitost zdravila Kalydeco pri bolnikih s cistično fibrozo, ki so imeli mutacijo R117H.
A fourth study was carried out with ProQuad (a vaccine that contains similar weakened viruses to those of M-M-RVAXPRO) given as two doses.
Četrta študija je bila izvedena z zdravilom ProQuad (cepivom, ki vsebuje podobne oslabljene viruse kot cepivo M-M-RVAXPRO),danim v dveh odmerkih.
A French compassionate use program included children from 6 months of age because the diagnosis of Dravet’s syndrome may be made with confidence at that age in some patients.
V francoski program sočutne uporabe so vključili otroke starejše od 6 mesecev, ker lahko diagnozo Dravetovega sindroma pri nekaterih bolnikih z gotovostjo postavimo šele pri tej starosti.
a Frequency is based on adverse event data.
a Pogostnost temelji na podatkih o neželenih dogodkih.
a From a 2-sided log-rank test.
a iz dvostranskega log-rang testa
a Full analysis set (FAS)
a Niz celotne analize (FAS, full analysis set)
a Full analysis set (FAS) - Completers using last observation carried forward (LOCF) prior to glycaemic rescue therapy
a Niz celotne analize (FAS, full analysis set) - osebe, ki so študijo dokončale, z uporabo zadnjega opazovanja prenesenega naprej (LOCF, last observation carried forward) pred uporabo reševalnega zdravljenja za ureditev glikemije
a Full analysis set (FAS) using last observation carried forward (LOCF) prior to glycaemic rescue therapy b Up to 4 mg glimepiride
a Niz celotne analize (FAS, full analysis set) z uporabo zadnjega opazovanja prenesenega naprej (LOCF, last observation carried forward) pred uporabo reševalnega zdravljenja za ureditev glikemije b Do 4 mg glimepirida
a Full analysis set (FAS) using last observation carried forward (LOCF) prior to glycaemic rescue therapy bSubgroup analysis for patients on additional background of metformin (FAS, LOCF)
a Niz celotne analize (FAS, full analysis set) z uporabo zadnjega opazovanja prenesenega naprej (LOCF, last observation carried forward) pred uporabo reševalnega zdravljenja za ureditev glikemije b Analiza pri podskupinah bolnikov ob prisotnosti metformina (FAS, LOCF)
A further 162 patients with HES/CEL, reported in 35 published case reports and case series received Glivec at doses from 75 mg to 800 mg daily.
Nadaljnjih 162 bolnikov s HES/CEL, o katerih so poročali v 35 objavljenih opisih primerov in skupinah primerov, je prejemalo zdravilo Glivec v odmerkih od 75 mg do 800 mg na dan.
A further 162 patients with HES/CEL, reported in 35 published case reports and case series received imatinib at doses from 75 mg to 800 mg daily.
Nadaljnjih 162 bolnikov s HES/CEL, o katerih so poročali v 35 objavljenih opisih primerov in skupinah primerov, je prejemalo imatinib v odmerkih od 75 mg do 800 mg na dan.
A further 162 patients with HES/CEL, reported in 35 published case reports and case series received imatinib at doses from 75 mg to 800 mg daily.
Nadaljnjih 162 bolnikov s HES/CEL, o katerih so poročali v 35 objavljenih opisih primerov in skupinah primerov, je prejemalo zdravilo Imatinib Actavis v odmerkih od 75 mg do 800 mg na dan.